Actively Recruiting

Age: 18Years +
All Genders
NCT06413212

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Led by Liu Huang · Updated on 2025-06-04

55

Participants Needed

1

Research Sites

121 weeks

Total Duration

On this page

Sponsors

L

Liu Huang

Lead Sponsor

B

Beijing GeneX MedLab Co., Ltd

Collaborating Sponsor

AI-Summary

What this Trial Is About

To explore the consistency between result of PTC drug screening tests and actual clinical outcome for patients with advanced malignancy.

CONDITIONS

Official Title

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 75 years, any gender
  • Nutrition risk screening 2002 (NRS2002) score less than 3
  • Advanced and unresectable malignancy confirmed by biopsy
  • Ability to tolerate anti-tumor treatment without serious cardiopulmonary or other underlying diseases
  • Eastern Cooperative Oncology Group (ECOG) score 2 or lower
  • Expected survival time longer than six months
  • At least one measurable lesion according to RECIST 1.1
  • Resistance or intolerance to standard therapy regimens
  • Voluntary signing of informed consent form
Not Eligible

You will not qualify if you...

  • Pregnant or breastfeeding women
  • Participation in other clinical trials within the past six months
  • Severe liver dysfunction
  • Severe kidney dysfunction
  • Cognitive disorder, mental illness, or poor compliance
  • Allergy to known chemotherapeutic agents
  • Any other condition deemed unsuitable for participation by investigators

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Tongji Hospital

Wuhan, Hubei, China, 430030

Actively Recruiting

Loading map...

Research Team

L

Liu Huang

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here